Fate Therapeutics
FATE
FATE
169 hedge funds and large institutions have $203M invested in Fate Therapeutics in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 54 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
61% less capital invested
Capital invested by funds: $520M → $203M (-$317M)
87% less call options, than puts
Call options by funds: $4K | Put options by funds: $31K
Holders
169
Holding in Top 10
1
Calls
$4K
Puts
$31K
Top Buyers
| 1 | +$3.05M | |
| 2 | +$2.62M | |
| 3 | +$1.79M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.08M |
| 5 |
BlackRock
New York
|
+$1.07M |
Top Sellers
| 1 | -$17M | |
| 2 | -$7.96M | |
| 3 | -$4.55M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$3.97M |
| 5 |
Citigroup
New York
|
-$2.26M |